Cabaletta Bio Income Statement (2018-2025) | CABA

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter)
6.56M7.85M8.17M9.92M9.17M9.51M8.22M12.40M12.44M11.80M13.79M17.41M21.95M23.43M26.29M23.00M29.02M37.64M39.82M36.19M
Selling, General & Administrative (Quarter)
3.16M3.29M3.39M3.97M3.83M3.55M3.56M3.90M4.52M4.09M4.88M5.74M6.08M6.85M6.76M8.25M8.12M8.27M6.76M6.42M
Other Operating Expenses (Quarter)
-0.06M0.50M-0.08M
Operating Expenses (Quarter)
9.71M11.14M11.56M13.89M13.00M13.06M11.78M16.30M16.96M15.89M18.67M23.15M28.03M30.28M33.05M33.78M37.14M45.91M46.59M42.61M
Operating Income (Quarter)
-9.71M-11.14M-11.56M-13.89M-13.00M-13.06M-11.78M-16.30M-16.96M-15.89M-18.67M-23.15M-28.03M-30.28M-33.05M-33.78M-37.14M-45.91M-46.59M-42.61M
EBIT (Quarter)
-9.71M-11.14M-11.56M-13.89M-13.00M-13.06M-11.78M-16.30M-16.96M-15.89M-18.67M-23.15M-28.03M-30.28M-33.05M-33.78M-37.14M-45.91M-46.59M-42.61M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.01M0.00M0.01M0.05M0.15M0.35M0.61M1.10M1.40M2.22M2.26M2.98M2.68M2.42M1.95M1.49M1.41M1.81M1.33M
Net income details
EBT (Quarter)
-9.70M-11.14M-11.56M-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M
Profit After Tax (Quarter)
-9.70M-11.14M-11.56M-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.13M-44.87M-41.92M
Income from Continuing Operations (Quarter)
-9.70M-11.14M-11.56M-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M
Consolidated Net Income (Quarter)
-9.70M-11.14M-11.56M-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M
Income towards Parent Company (Quarter)
-9.70M-11.14M-11.56M-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M
Net Income towards Common Stockholders (Quarter)
-9.70M-11.14M-11.56M-13.89M-12.95M-12.91M-11.43M-15.69M-15.85M-14.49M-16.45M-20.89M-25.05M-27.60M-30.63M-32.59M-35.94M-45.07M-45.36M-41.84M
Additional items
EPS (Basic) (Quarter)
-0.41-0.45-0.45-0.49-0.45-0.45-0.39-0.52-0.45-0.37-0.37-0.47-0.51-0.56-0.62-0.65-0.71-0.73-0.44-0.35
EPS (Weighted Average and Diluted) (Quarter)
-0.45-0.45-0.49-0.45-0.45-0.39-0.52-0.45-0.37-0.37-0.47-0.51-0.56-0.62-0.65-0.71-0.73-0.44-0.35
Shares Outstanding (Weighted Average) (Quarter)
4.57M20.42M4.40M21.36M4.11M25.13M3.70M4.13M4.13M2.35M1.17M47.86M48.40M0.62M10.80M6.00M53.09M
EBITDA (Quarter)
-9.71M-11.14M-11.56M-13.88M-13.10M-13.01M-11.39M-15.53M-15.81M-14.49M-16.47M-20.78M-25.12M-27.59M-30.60M-32.59M-35.94M-45.13M-44.84M-41.92M
Interest Expenses (Quarter)
0.75M0.29M0.57M0.58M0.56M